Multiple Myeloma MajesTEC-7 – 64007957MMY3005
Study #64007957MMY3005Description
A Phase 3 Randomized Study Comparing Teclistamab in Combination with Daratumumab SC and Lenalidomide and Talquetamab in Combination with Daratumumab SC and Lenalidomide versus Daratumumab SC, Lenalidomide, and Dexamethasone in Participants with Newly Diagnosed Multiple Myeloma Who are Either Ineligible or not Intended for Autologous Stem Cell Transplant as Initial Therapy.
Interested in this trial? Email [email protected].
Back To Clinical Trials